StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$941.25−6.27 (-0.66%)

Close on Nov 18, 2026Market cap –P/E 48.1Yield –

argenx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

argenx's price to sales ratio was 40.8× on Feb 28, 2023, against 360.4× a year earlier. Over the last 4 years it ranged from 29.9× to 436.4×, with a median of 200.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 202340.8×−1.2
2022Dec 30, 202241.9×−394.5
2021Dec 31, 2021436.4×+276.1
2020Dec 31, 2020160.3×−108.5
2019Dec 31, 2019268.8×–

More argenx figures

See a number that looks wrong?